Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
68,00 AOD-9604 - Fat Metabolism & Weight Regulation Peptide Aids in the metabolic process of accelerating stored fatty acid breakdown into usable energy Supports the suppression of new fat cell formation in adipose tissue Observed to avoid negative impact on glucose tolerance or insulin sensitivity Delivers metabolic support without increasing IGF-1 levels or causing systemic growth effects Showed high tolerability in human trials, comparable to placebo Clinical studies indicated no anti-AOD-9604 antibodies were detected Preclinical research suggests potential for promoting repair and regeneration in joint models Research indicates potential for lowering cholesterol and triglycerides in metabolic studies Description AOD-9604 is a synthetic fragment of human growth hormone (HGH 177-191) designed to selectively enhance fat metabolism without influencing growth-promoting or insulin-modulating pathways
Prospective evaluation of hCG in the investigation of cryptorchidism [PMID: 2574929] Laboratory literature summary: Prospective evaluation of hCG in the investigation of cryptorchidism
(d) review articles or non-clinical studies
It was found that both AOD9604 and hGH resulted in fat loss in association with increased fat oxidation as well as increased levels of glycerol (relating to lipolysis), However, an added benefit of AOD9604 was that it did not lead to hyperglycemia in the mice or reduced insulin sensitivity
These effects are highest during the titration phase, typically peaking around weeks 6-8 of use, and resolve for the majority of participants as the body adapts, usually by week 10-12
